Table 2.
Comparison of selected coagulation, hematology, and blood chemistry parameters among various NYHA functional classes of CHF group and control group.
|
Control (n = 50) |
NYHA functional class |
Total patients (n = 58) |
||||
|---|---|---|---|---|---|---|
| I (n = 2) |
II (n = 19) |
III (n = 32) |
IV (n = 5) |
|||
| PT (sec.) | 7.1 ± 0.51a | 7.0 ± 0.1abc | 6.9 ± 0.3ab | 6.8 ± 0.3bc | 6.5 ± 0.3c | 6.9 ± 0.32 |
| APTT (sec.) | 12.2 ± 0.71a | 12.3 ± 0.3a | 12.0 ± 0.4a | 12.0 ± 0.6a | 11.7 ± 0.4a | 12.0 ± 0.51 |
| Fibrinogen (mg/dL) | 175.2 ± 37.41a | 223.5 ± 55.0ab | 268.8 ± 88.5b | 275.9 ± 99.5b | 351.8 ± 83.9c | 278.3 ± 94.92 |
| D-dimer (μg/mL) | 117.2 ± 36.91a | 197.0 ± 45.3ab | 419.2 ± 173.2b | 742.8 ± 300.6c | 1349.8 ± 445.4d | 670.3 ± 380.72 |
| ATIII (%) | 112.6 ± 16.51a | 88.7 ± 4.5abc | 87.2 ± 21.0b | 84.7 ± 27.1b | 59.2 ± 23.1c | 83.5 ± 25.22 |
| PC (%) | 110.2 ± 12.91a | 99.8 ± 8.3ab | 101.2 ± 24.6ab | 93.3 ± 33.3b | 57.3 ± 21.7c | 93.0 ± 31.12 |
| F.VII (%) | 99.9 ± 15.81a | 101.0 ± 8.5ab | 124.6 ± 36.5b | 125.8 ± 23.5b | 132.9 ± 15.9b | 125.2 ± 27.72 |
| F.VIII (%) | 98.1 ± 12.91a | 112.4 ± 10.5ab | 124.7 ± 29.0b | 124.0 ± 26.0b | 139.3 ± 10.2b | 125.1 ± 25.82 |
| HCT (%) | 37.4 ± 3.01a | 42.5 ± 2.3ab | 42.4 ± 6.7b | 41.8 ± 7.0b | 41.0 ± 8.2ab | 42.0 ± 6.72 |
| PLT (×103/μL) | 259.8 ± 45.51a | 257.5 ± 109.6ab | 359.5 ± 122.8b | 355.5 ± 136.3b | 304.8 ± 104.7ab | 349.1 ± 128.02 |
| TP (g/dL) | 6.5 ± 0.51a | 7.0 ± 0.3ab | 7.6 ± 1.0b | 7.5 ± 1.5b | 6.7 ± 1.1ab | 7.5 ± 1.32 |
| ALB (g/dL) | 3.1 ± 0.31a | 3.4 ± 0.6ab | 3.5 ± 0.6b | 3.4 ± 0.5b | 2.9 ± 0.5a | 3.4 ± 0.62 |
1,2Different superscript numbers indicate statistical significance between MVD group and control group at P < 0.05. a,b,c,dDifferent superscript letters indicate statistical significance among various NYHA classes of CHF group and control group at P < 0.05.